Award

Delivery Order #SPE2DR26F1DQ4

AmerisourceBergen Delivery Order for Myrbetriq ER Tablets

Buyer

Defense Logistics Agency

Award Amount

$5,154.91

Ceiling

$5,154.91

Awarded

March 16, 2026

Period of Performance

Mar 16, 2026 – Mar 17, 2026

Identifier

SPE2DR26F1DQ4

NAICS

424210

This award represents a definitive delivery order contract under an existing indefinite delivery vehicle (IDV) awarded to AmerisourceBergen Drug Corporation, a prominent healthcare solutions provider specializing in pharmaceutical distribution. The contract pertains to the procurement of Myrbetriq ER 25 mg tablets, a pharmaceutical product critical for treatment purposes. This specific delivery order supports the ongoing fulfillment of healthcare facilities' medication needs, ensuring timely availability of essential drugs. AmerisourceBergen's role in this and the parent IDV contract underscores its importance in maintaining a reliable pharmaceutical supply chain for public health sectors. The delivery order was competitively procured within the framework of the established IDV contract, reflecting AmerisourceBergen's proven capability and trusted service. The performance period for this order is brief, spanning a two-day window, aligning with urgent or specific delivery requirements. Overall, the contract highlights the agency's continued investment in streamlined pharmaceutical procurement to safeguard public health.

Description

4571166054!MYRBETRIQ ER 25 MG TABLET 90S

View original record